2015 年 3 月 11 日,复旦大学附属中山医院多发性骨髓瘤多学科协作组正式成立。在血液科刘澎主任的领导下,血液科联合检验科、病理科、核医学科、肾内科、骨科、神经内科共同举办了成立大会。然而,这仅是序曲,MDT 正在谱写更加辉煌的乐章。
Prof. Philippe Moreau, MD, is Head of the Hematology Department at the University Hospital of Nantes, France. He specializes in clinical hematology, with a particular focus on multiple myeloma and its treatment with high-dose therapy and novel agents. Prof. Moreau was appointed University Professor of Clinical Hematology at Nantes Faculty of Medicine in 2003.
As leading researcher in multiple myeloma, Prof. Moreau is head of the unit for early phase 1 and phase 2 trials in clinical hematology at the University Hospital of Nantes. Additionally, he was a member of the organizing committee for the 2011 International Myeloma Workshop, in Paris. Prof. Moreau is currently a member of the administration council f the Intergroupe Francophone du Myélome (IFM), and he was chairman of the IFM from 2006 through 2009.
Prof. Moreau is widely published, with more than 240 per-reviewed articles and reviews that have appeared in high impact factor journals including New England Journal of Medicine, Journal of Clinical Oncology, Lancet Oncology, and Blood.
点击「阅读原文」,获取邀请函
联系客服